Concurrent nonalcoholic fatty liver disease and type 2 diabetes: diagnostic and therapeutic considerations-Reference-Cited by-同舟云学术

Concurrent nonalcoholic fatty liver disease and type 2 diabetes: diagnostic and therapeutic considerations

Published:2019-08-08 Issue:9 Volume:13 Page:849-866
ISSN:1747-4124
Container-title:Expert Review of Gastroenterology & Hepatology
language:en
Short-container-title:Expert Review of Gastroenterology & Hepatology

Author:

Arrese Marco¹²^ORCID,Barrera Francisco¹^ORCID,Triantafilo Nicolas³,Arab Juan Pablo¹^ORCID

Affiliation:

1. Departamento de Gastroenterología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile

2. Departamento de Biología Celular y Molecular, Facultad de Ciencias Biológicas Pontificia Universidad Católica de Chile, Centro de Envejecimiento y Regeneración (CARE), Santiago, Chile

3. Departamento de Hematologia y oncología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile

Publisher

Informa UK Limited

Subject

Gastroenterology,Hepatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474124.2019.1649981

Reference213 articles.

1. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

2. Non-alcoholic fatty liver disease – A global public health perspective

3. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease

4. Obesity: global epidemiology and pathogenesis

5. Worldwide trends in insufficient physical activity from 2001 to 2016: a pooled analysis of 358 population-based surveys with 1·9 million participants

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fatty liver disease - non alcoholic to metabolic - A transition of concepts!!;Journal of Family Medicine and Primary Care;2024-07-26

2. Impact of Obesity on Target Organ Damage in Patients with Metabolic Syndrome;Diagnostics;2024-07-19

3. The Janus of a disease: Diabetes and metabolic dysfunction-associated fatty liver disease;Annals of Hepatology;2024-07

4. Metabolic dysfunction-associated fatty liver disease and nonalcoholic fatty liver disease from clinical to pathological characteristics: a multi-center cross-sectional study in real world;Postgraduate Medical Journal;2024-01-25

5. Emerging Drug Therapies for Metabolic Dysfunction-Associated Steatotic Liver Disease: A Glimpse into the Horizon;Current Hepatology Reports;2024-01-06